Why combine them
Each compound does one thing well, and one thing it can't do at all.
Enclomiphene drives endogenous production. Your testes wake up, your sperm count rises, your HPG axis stays intact. The catch: the lift is bounded by what your testes can biologically produce — typically 30–60% above baseline.
Testosterone cream supplies hormone directly. The lift is dose-dependent and can be substantial — but the body responds by shutting down its own production. Sperm suppression follows.
Stack them and the math changes. The cream supplies what your testes alone couldn't. The enclomiphene keeps the testes working anyway, despite the supplemental cream telling the brain "we have plenty." Your sperm count stays normal. Your testosterone climbs to optimal range.
Hybrid is the only protocol that gives you near-injectable Total T levels while keeping your testes online and your fertility intact. It's why our medical director calls it "have-it-all."
How it works in practice
- One pill in the morning. Enclomiphene 12.5 mg. With or without food.
- Cream application after. 0.5 mL pumped onto two fingers. Rubbed into the inner upper arm. 90 seconds.
- That's it. Total daily routine: about two minutes.
What the bloodwork tends to show
| Marker | Forge (cypionate) | Spark (enclomiphene) | Hybrid (this protocol) |
|---|---|---|---|
| Total T lift | +650 ng/dL | +218 ng/dL | +498 ng/dL |
| LH / FSH | Suppressed | Elevated | Preserved or elevated |
| Sperm production | Suppressed | Increased | Preserved or increased |
| Hematocrit risk | Higher | Minimal | Moderate |
| Reversibility | Months off | Weeks off | Weeks off |
Median outcomes from the Dominant cohort. Your numbers will vary. Your physician will tell you yours.
Side effects
Hybrid inherits the side-effect profile of both compounds, scaled down because the cream dose is lower than monotherapy and the enclomiphene is doing some of the work:
- Hematocrit may rise modestly — monitored every panel.
- Estradiol can rise (cream component) — monitored.
- Skin transfer risk on cream side — manageable with the same protocol as Ember.
- Visual or mood effects from enclomiphene — rare, usually transient.
Who it's for
- Men who want max-level optimization but plan to have kids in the next few years.
- Men who need a steeper lift than Spark alone can deliver.
- Men who don't want to inject anything.
- Men who'd rather pay slightly more to keep all their options open biologically.
Who it's wrong for
- Men with primary testicular failure — enclomiphene component won't work.
- Men who prefer the simplicity of a single weekly injection.
- Men actively trying to conceive in the next 90 days — Spark monotherapy is gentler on sperm in the short window.
What we monitor
Full panel: Total T, Free T, SHBG, LH, FSH, Estradiol, Hematocrit, PSA, Lipids, Liver. Baseline, week 8, week 16, quarterly. Plus optional sperm analysis if conception is on the horizon.
Hybrid is the protocol I'd put on my own brother if he asked. Maximum lift, minimum trade-offs.— Dominant medical director
The bottom line
Two compounds, two pathways, one outcome: optimal Total T with fertility online. It's a few dollars more per month than monotherapy. For the right patient, it's worth every cent.